Ferrolin

Quick links to important sections

Ferrolin

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferrolin

What is Ferrolin?

Ferrolin is an iron-based dietary supplement formulated to support the body's iron levels and contribute to the normal formation of red blood cells and hemoglobin. It is primarily used to address nutritional deficiencies or to meet increased physiological requirements for iron.

Composition and Mechanism

The supplement typically contains iron in a bioavailable form, often combined with other synergistic nutrients such as Vitamin C, Vitamin B12, and folic acid. These additional components are included to facilitate the absorption of iron and support overall blood health.

  • Iron: A fundamental mineral required for the transport of oxygen throughout the body via hemoglobin.
  • Vitamin C: Enhances the intestinal absorption of non-heme iron.
  • B-Vitamins: Support the metabolic processes involved in the production of healthy red blood cells.

General Use

Iron is an essential microelement involved in various biological functions, including energy metabolism and the maintenance of the immune system. Ferrolin is intended for individuals who may have a reduced intake of iron through their diet or who experience physiological states where the demand for iron is higher, such as during periods of intense physical activity or specific developmental stages.

By helping to maintain adequate iron stores, the supplement aims to reduce feelings of tiredness and fatigue associated with low iron levels.

Regulatory References

  1. NIH ODS Iron Fact Sheet
  2. Iron deficiency anemia: MedlinePlus

What side effects are possible with Ferrolin?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and safety restrictions for Ferrolin, based strictly on government regulatory documents.

Adverse Reactions

The safety profile primarily highlights effects related to the gastrointestinal system, classified by regulatory authorities using standard frequency categories.

Classification System-Organ Class
Common Gastrointestinal disorders
(Frequency Not Known) Allergic skin reactions

Common adverse reactions typically include gastrointestinal disturbances such as constipation, diarrhea, nausea, vomiting, and abdominal pain. The frequency of these effects may be related to the dosage administered.

Safety Restrictions and Contraindications

Ferrolin is subject to specific safety limitations defined in regulatory labeling to prevent serious harm:

  • Contraindications: The medicine is strictly forbidden for use in patients with known hypersensitivity (allergy) to the active substance or any of its components. It is also contraindicated in all patients with medical conditions that lead to iron overload, such as hemochromatosis, as this can result in severe organ damage.
  • Serious Risk of Overdose: A mandatory and prominent regulatory warning is in place regarding the potential for fatal poisoning from accidental overdose of iron-containing products in young children. This constitutes a severe medical emergency.

Safety Profile Summary

The medicine's regulatory safety profile is structured to first define the most frequently reported side effects (gastrointestinal). It then establishes absolute contraindications to prevent use in high-risk patients (those with iron overload or hypersensitivity). Finally, a critical safety statement addresses the serious pediatric overdose hazard that is characteristic of oral iron products.

Overdose and Emergency Response

Accidental overdose of products containing iron, such as Ferrolin, is a leading cause of fatal poisoning in children under 6 years of age. Due to this high risk, it is critical to keep the product out of the reach of children and to seek immediate medical help if accidental ingestion is suspected.

Overdose with this iron formulation (ferric maltol) can lead to iron overload and the potential for serious systemic toxicity. Early signs and symptoms of iron overdose may include gastrointestinal manifestations such as nausea, vomiting, abdominal pain, and diarrhea. The vomit and stools may appear grey or black. In severe cases, patients may experience metabolic acidosis, hypoperfusion, systemic toxicity, and potentially progress to shock or organ failure.

Use of Ferrolin is specifically restricted for individuals with pre-existing iron overload conditions, such as hemochromatosis or other iron overload syndromes, or for those receiving repeated blood transfusions, as these circumstances may result in a rapid iron overdose. If any suspicion of accidental overdose occurs, immediately call a doctor or a poison control center.

Overdose Symptoms (Early Phase) Population-Specific Risk Required Action
Nausea, vomiting, abdominal pain, diarrhea Children under 6 years old Get medical help right away
May progress to hypoperfusion and shock Patients with iron overload syndromes Call a poison control center immediately

Therapeutic Uses of Ferrolin

What Ferrolin Treats: Main Uses and Benefits

Ferrolin is commonly used when short-term symptomatic assistance is needed across domains related to iron deficiency, which is generally associated with fatigue and systemic discomfort. It is applied in contexts where additional symptomatic support is needed during phases when symptoms become more noticeable.

Symptom Relief and Supportive Use

Ferrolin offers symptomatic relief that helps ease the overall burden of persistent fatigue and generalized physical weakness. It is applied across domains where additional symptomatic support is needed, contributing to improved comfort during periods of heightened symptoms. It is considered relevant for easing symptoms related to systemic imbalance, including lightheadedness and general malaise. It is commonly used across conditions where symptoms may intensify temporarily.

This supplement is applied in situations involving recurrent or episodic manifestations, providing assistance when symptoms intensify and supportive relief is needed. Iron supplements are a key part of management for iron deficiency anemia, a condition associated with feeling weak or tired.

The main areas of symptomatic application include managing fatigue and addressing functional strain, relevant across conditions marked by increased physiological stress.

“It helps address symptom clusters that may become intense or disruptive and are associated with iron deficiency.”


Quick Fact: Support for Pronounced Weakness

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Ferrolin’s official eligibility profile is structured around mandatory restrictions and conditional use defined by government health authorities. While generally permitted for adult populations seeking dietary iron support, strict prohibitions apply to protect specific vulnerable groups.

Groups Not Eligible for Ferrolin Use

Use of this iron supplement is absolutely contraindicated in the following populations, as stated in regulatory documentation:

  • Children under the age of 6: Use is strictly prohibited due to the mandatory regulatory warning concerning the risk of fatal accidental poisoning from accidental overdose.
  • Patients with Iron Overload: Individuals diagnosed with conditions like Hemochromatosis or Hemosiderosis must not use the product, as iron supplementation is counterproductive and may lead to toxic accumulation.

Conditional Use and Restrictions

Eligibility requires caution or specific conditions in other populations:

  • Age-Group Restriction: Children aged 6 and older are eligible only for age-appropriate iron formulations; adult products are strictly prohibited for this age group.
  • Pre-existing Conditions: Patients with active Gastrointestinal Ulcers, a history of GI Bleeding, Liver Disease, or certain non-iron deficiency blood disorders must have use determined and managed by a healthcare provider.
  • Pregnancy and Lactation: Use is conditional during pregnancy and breastfeeding. While often recommended for nutritional support, use must be discussed with a provider for proper supervision.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ferrolin's interaction profile is primarily defined by the physicochemical properties of its iron component, which can interfere with the absorption of co-administered medicines, as documented in official government labeling. The presence of Ascorbic Acid (Vitamin C), an intentional component of the formulation, is officially documented to increase the absorption of the iron itself.


Pharmacokinetic Interference and Timing Rules

Co-administration with oral iron officially results in reduced systemic exposure for several medicinal product categories, primarily due to chelation or binding. The following substances require mandatory temporal separation to mitigate this effect and maintain their effectiveness:

  • Antibiotics (Quinolones and Tetracyclines): Iron officially decreases the bioavailability of these agents. Administration must be separated by 2–4 hours for Quinolones and 2–3 hours for Tetracyclines, according to regulatory labeling.
  • Levothyroxine (Thyroid Hormones): Iron officially reduces the efficacy and absorption of levothyroxine, necessitating an administration separation of 2–3 hours.
  • Bisphosphonates and Anti-Parkinson’s Medicines: Iron is officially documented to interfere with the absorption and subsequent exposure of these products, requiring a separation of doses.

Interactions with Supplements and Remedies

Regulatory documents state that certain non-prescription products officially reduce the absorption of the iron preparation. These include Antacids, Calcium supplements, and Indigestion remedies containing Magnesium or Aluminium.

Mechanism of Action

Ferrolin is a formulation that delivers elemental iron, Vitamin C (ascorbic acid), Vitamin B12 (cyanocobalamin), and Folic Acid (folate) to modulate specific biochemical pathways.

The core mechanistic cascade begins with the intestinal uptake of iron. Iron, typically in the ferric (Fe^3+) state, is first reduced to the ferrous (Fe^2+) state by duodenal ferrireductases. Vitamin C acts as a reducing agent, enhancing the conversion of luminal Fe^3+ to the absorbable Fe^2+ form. This Fe^2+ ion is then transported across the apical membrane of the enterocyte via the Divalent Metal Transporter 1 (DMT1). Following cellular assimilation, Fe^2+ is exported into the bloodstream by the basolateral transporter Ferroportin, where it is oxidized back to Fe^3+ and captured by the plasma protein Transferrin for systemic delivery.

Once circulating, the iron is delivered to tissues, particularly the bone marrow, where it is incorporated into the protoporphyrin ring to construct the Heme complex. This Heme complex then integrates with globin chains to form Hemoglobin, the quaternary protein structure responsible for oxygen binding and transport.

Concurrently, Folic Acid (folate) functions as a cofactor in one-carbon metabolism, playing an essential role in the synthesis of purines and pyrimidines, which are critical precursors for DNA and RNA. Vitamin B12 (cyanocobalamin) is an obligatory coenzyme for the enzyme methionine synthase, linking it directly to folate cycling, which is essential for proper DNA synthesis and subsequent cell division, including that of erythroid progenitor cells.

Dosage and Administration Information

How to Use Ferrolin: Administration Guidelines

Ferrolin is administered via the oral route (by mouth). Instructions for correct dosing, timing, and administration are provided to ensure the medicine is taken as intended.


Administration Instructions

The medicine is typically taken once daily. The general standard daily dosage is 1 capsule for adults and the elderly. In cases where the deficiency is more severe, the dose may be increased to 2 capsules daily.

For maximum absorption, the medicine is intended to be taken on an empty stomach. However, the medicine may be taken with or immediately after food to help minimize potential gastrointestinal irritation. When taking the capsule, it should be swallowed whole. If a patient is unable to swallow the capsule, instructions permit the capsule to be opened and the contents mixed with soft, cool food, but the contents must not be chewed.


Age-Specific and Contextual Rules

Age/Population Dosing Schedule Special Condition
Adults/Elderly 1 capsule daily (up to 2 in severe cases) Swallow whole; do not chew.
Children (over 1 year) 1 capsule daily Capsule contents may be mixed with soft, cool food.
Pregnancy Prophylaxis justified after the first trimester Avoidance in the first trimester unless iron deficiency is confirmed.

Use in the first trimester of pregnancy should be avoided unless there is definite, clinical evidence of iron deficiency. The prophylactic (preventive) use of the medicine is justified during the remainder of the pregnancy.

Recent Clinical Evidence

Ferrolin: Recent Clinical Evidence

Evidence for Use in Iron Deficiency Anemia (IDA)

Research has examined iron preparations, which provide the active ingredient in Ferrolin, primarily in individuals diagnosed with Iron Deficiency Anemia (IDA). This research includes Randomized Controlled Trials (RCTs) and Systematic Reviews used in research exploring how symptoms change over time. The outcomes studied focused on core blood iron biomarkers like Hemoglobin (Hgb) and Serum Ferritin (SF). Studies also monitored patient-reported outcomes describing perceived discomfort, such as fatigue and general weakness. Studies examined tolerability outcomes, monitoring reports of self-reported gastrointestinal symptoms across different formulations.

Research findings describe the evidence landscape regarding changes in iron status that were observed when using iron supplements. However, results apply only to the specific populations studied, and certainty remains low regarding long-term effects, as follow-up durations were typically limited to about six months. Comparative evidence is limited in research exploring every specialized iron formulation against older iron salts in large-scale studies.


Evidence for Addressing Non-Anemic Iron Deficiency and Fatigue

Iron supplementation was evaluated in individuals with Non-Anemic Iron Deficiency (NAID) who experience fatigue. Research explores short-term symptom changes in conditions characterized by fluctuating or episodic manifestations of fatigue. The studies monitored changes in Serum Ferritin (SF) alongside patient-reported outcomes related to physical fatigue. Findings show patterns related to an association between iron supplementation and changes in fatigue. However, the evidence quality varies across studies, and findings were mixed in some reports. A key research limitation is the inconsistent diagnostic criteria used across studies for defining NAID.


Summary of Evidence Gaps and Areas of Uncertainty

The research provides context, but evidence highlights what is known—and what is still uncertain. Long-term effects are not fully established because follow-up durations were limited in many key RCTs. Data for certain subgroups, such as older adults with multiple chronic conditions, remain insufficient. The results apply only to the populations studied, and the overall evidence quality varies across studies.

Key Studies & References

  1. Iron in Diet - MedlinePlus Medical Encyclopedia
  2. Iron deficiency anemia: Symptoms, diagnosis, and treatment - NIH MedlinePlus Medical Encyclopedia
  3. Oral iron preparations for iron deficiency anaemia in adults and children: a clinical effectiveness review
  4. Vitamin C and Iron Absorption: Physiology and Pathophysiology

Frequently Asked Questions (FAQ)

Common questions about Ferrolin (FAQ)

Q: Is Ferrolin used to treat more than one medical condition?

A: Official information describes the primary role of iron supplementation in addressing established Iron Deficiency Anemia (IDA). It also serves a broader purpose as a supplement to support general iron levels and assist in the reduction of physical fatigue in cases of nutritional insufficiency. This distinction is based on the specific condition being managed.

Q: What is the difference between Ferrolin and a standard iron supplement?

A: Ferrolin is a specific formulation that utilizes a specialized iron complex. The product information describes it as having a reduced potential for gastrointestinal irritation when compared to older, traditional ferrous iron salts. It is also formulated with co-factors like B vitamins and Vitamin C.

Q: Does Ferrolin carry a Boxed Warning in regulatory documents?

A: Regulatory labeling contains a prominent and mandatory warning concerning the serious risk of fatal accidental poisoning from iron-containing products. This critical statement addresses the pediatric overdose hazard, which is a required safety communication for all such oral iron supplements.

Q: Are there any foods or beverages that should be avoided when taking Ferrolin?

A: Official guidance on use conditions indicates that the supplement may need temporal separation from certain items that can reduce iron absorption. This includes foods and beverages high in calcium, as well as coffee or black tea. Regulatory information suggests a separation of at least two hours to optimize absorption of the iron component.

Q: Should I take Ferrolin at the same time as dairy products?

A: Regulatory guidance points out that iron supplements should be separated from dairy products due to their high calcium content. Calcium is known to interfere with the body's ability to absorb iron from the supplement. Official information indicates that leaving a separation of at least two hours between taking Ferrolin and consuming dairy products helps optimize absorption.

Q: Is Ferrolin appropriate for use by children?

A: Ferrolin is strictly prohibited for use in children under the age of six due to the mandatory safety warning concerning the risk of fatal accidental poisoning. Children over the age of six may be eligible, but they must use age-appropriate formulations only.

Q: Is Ferrolin described as safe for mothers who are nursing or breastfeeding?

A: Use during breastfeeding or lactation is described as conditional in regulatory documents. Official guidance requires that use during this period be under the supervision of a healthcare provider.

Q: Is Ferrolin suitable for people who have thalassemia or hemolytic anemia?

A: Official product safety information indicates the supplement is strictly forbidden in patients with conditions that lead to iron overload in the body. Because conditions like thalassemia or hemolytic anemia can be associated with excess iron, eligibility for use must be determined and managed by a healthcare provider.

Q: How does the structure of Ferrolin differ from other iron salts like ferrous fumarate?

A: Ferrolin utilizes specific iron complexes in its formulation. This design choice is aimed at achieving targeted absorption and, according to studies, may result in fewer gastrointestinal side effects than iron delivered through older, standard iron salts.

Q: What does it mean if an official document mentions Ferrolin is 'not FDA-approved'?

A: Ferrolin is legally classified as an Over-the-Counter (OTC) dietary supplement. This classification places it under different regulatory requirements than a prescription drug, which must undergo the specific, full-scale clinical review process to receive FDA drug approval.

Q: Are there different formulations of Ferrolin (e.g., tablet, liquid, extended-release)?

A: Official documents for iron products reference forms such as capsules, tablets, and liquid sachets. While research has examined the potential of extended-release formulations for some iron preparations, availability depends on the specific product authorized for sale.

Q: Is it normal to experience a change in stool color when taking Ferrolin?

A: Yes, regulatory labeling notes that dark or black stools are listed as a common and expected change when taking oral iron supplements. This change is typically due to unabsorbed iron passing through the digestive tract.

Q: Does Ferrolin interact with common over-the-counter pain relievers?

A: Official drug interaction tables do not list specific interactions with common over-the-counter pain relievers. However, general regulatory rules for temporally separating all oral medications apply because the iron component can interfere with the absorption of many other medicines.

Q: What is a "drug-food interaction" in the context of Ferrolin?

A: A "drug-food interaction" describes a situation where taking the supplement at the same time as certain foods changes the way the supplement is absorbed by the body. In the context of Ferrolin, this refers to how certain foods, such as those high in calcium or caffeine, can reduce the amount of iron the body assimilates.

Q: Can Ferrolin cause a metallic taste in the mouth?

A: Yes, official safety information lists metallic taste as a possible side effect that may be experienced when taking oral iron supplements. This is generally a temporary and non-serious effect.

Q: Are there different eligibility criteria for older adults (seniors) using Ferrolin?

A: Regulatory dosing documents typically list the same standard dosage and general eligibility criteria for both adults and the elderly. This indicates that use is generally the same across these age groups, provided the patient does not have specific co-morbidities that may restrict iron use.

Q: What is the rate of absorption described for Ferrolin's active components?

A: Studies on oral iron supplementation describe that the body typically absorbs only a small percentage (around 10-20%) of the elemental iron content into the bloodstream. The formulation of Ferrolin is structured to support the bioavailability of its active components.

Q: What does the term "elemental iron" mean in relation to Ferrolin?

A: Elemental iron refers to the pure quantity of iron that is actually available for your body to absorb and use from the supplement. This is the crucial part needed to support essential functions, such as making hemoglobin.

Q: What is the risk of dental staining when using Ferrolin?

A: Temporary staining of the teeth is a documented risk, particularly when using liquid formulations of iron supplements. Official administration instructions often include guidance, such as mixing the liquid with water or juice, which is intended to reduce this effect.

Q: What happens if a dose of Ferrolin is missed?

A: Official guidance states that a missed dose is generally to be skipped entirely. The regulatory instruction is to then simply resume the regular dosing schedule at the next scheduled time and cautions against taking a double dose to make up for the one that was missed.

How should Ferrolin be stored and disposed of?

How to Store and Dispose of Ferrolin

Ferrolin must be stored strictly according to the conditions defined in regulatory labeling to maintain its stability and effectiveness. The product should be kept at room temperature, away from excess heat, and must be protected from both light and moisture; therefore, storage in the bathroom is prohibited. To prevent degradation, keep the medication in its original container and ensure the cap is tightly closed.

Child Safety and Disposal

Due to the significant risk of fatal poisoning from iron overdose, it is mandatory to keep this product out of the reach and sight of children at all times. Expired or unused Ferrolin should not be flushed down the toilet or poured down a drain. Instead, dispose of the medicine by using an authorized drug take-back program or by following the government-recommended household protocol for waste medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferrolin found in:

A-Z Index: